Skip to content
HowShorted

Teladoc Health, Inc. short interest in 2020

In 2020, Teladoc Health, Inc.'s disclosed short interest ran from 29.85% of shares outstanding on 15 Jan 2020 to 10.57% on 31 Dec 2020, a change of -19.28 percentage points. The year's high was 29.85% on 15 Jan 2020 and its low 8.48% on 31 Jul 2020, averaging 15.78% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.73 days on 14 Feb 2020. Full history: Teladoc Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Teladoc Health, Inc. in 2020

2020 in figures

Start of year
29.85% (15 Jan 2020)
End of year
10.57% (31 Dec 2020)
Change
-19.28 pp
High
29.85% (15 Jan 2020)
Low
8.48% (31 Jul 2020)
Average
15.78%
Highest days to cover
17.73 (14 Feb 2020)
SEC filings marked
9

Every report in 2020

Teladoc Health, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202029.85%16.41
31 Jan 202027.87%16.08
14 Feb 202025.71%17.73
28 Feb 202021.62%4.4510-K filed, results (8-K)
13 Mar 202018.41%3.93
31 Mar 202014.48%1.96
15 Apr 202013.87%4.29results (8-K)
30 Apr 202011.67%2.8610-Q filed, results (8-K)
15 May 202011.49%3.43
29 May 202010.22%2.85
15 Jun 202010.81%3.32
30 Jun 202010.08%2.27
15 Jul 202010.13%4.12
31 Jul 20208.48%4.7410-Q filed, results (8-K)
14 Aug 202015.12%1.62
31 Aug 202016.97%3.29
15 Sep 202019.49%5.72
30 Sep 202019.80%5.91
15 Oct 202020.01%8.41
30 Oct 202020.33%6.01results (8-K)
13 Nov 202010.61%3.3610-Q filed
30 Nov 202010.62%4.54
15 Dec 202010.60%7.40
31 Dec 202010.57%5.25

See also: Teladoc Health, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.